Vaxcyte, Inc. ($PCVX)
Filing Information
| Accession Number | 0001813798-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
94,520
Total Value
$550,499.34
P&L
+1475.9% (+$4,648,890.45)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF OPERATING OFFICER | Common Stock | โ | Feb 26, 2026 | Grant/Award | 32,045 | $0.00 | $0.00 | 173,893 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Feb 27, 2026 | Grant/Award | 5,102 | $61.74 | $314,997.48 | 178,995 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Feb 27, 2026 | Tax Withholding | 1,900 | $61.74 | $117,306.00 | 177,095 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Feb 28, 2026 | Tax Withholding | 898 | $61.98 | $55,658.04 | 176,197 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Mar 2, 2026 | Tax Withholding | 1,009 | $61.98 | $62,537.82 | 175,188 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Stock Option (right to buy) | Derivative | Feb 26, 2026 | Grant/Award | 53,566 | $0.00 | $0.00 | 53,566 | Direct | โ | View Details |